Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
IRONWOOD PHARMACEUTICALS INC (IRWD) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/02/2018 BW Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders
05/01/2018 BW Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business
05/01/2018 BW Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update
04/17/2018 BW Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call
02/15/2018 BW Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update
02/01/2018 BW Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Investor Update Call
11/02/2017 BW Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update
10/19/2017 BW Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call
08/03/2017 BW Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update
07/20/2017 BW Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call
05/08/2017 BW Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update
04/24/2017 BW Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
03/10/2017 BW Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
03/09/2017 BW Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017
02/21/2017 BW Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update
02/07/2017 BW Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call
08/11/2011 BW Ironwood Pharmaceuticals Provides Second Quarter 2011 Investor Update
08/10/2011 BW Ironwood Pharmaceuticals to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
05/31/2011 BW Ironwood Pharmaceuticals Announces Upcoming Presentations at Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference
05/12/2011 BW Ironwood Pharmaceuticals Provides First Quarter 2011 Investor Update
05/05/2011 BW Ironwood Pharmaceuticals to Host First Quarter 2011 Investor Update Call
03/03/2011 BW Ironwood Pharmaceuticals Announces Upcoming Presentation at Cowen and Company Annual Health Care Conference
03/03/2011 BW Ironwood Pharmaceuticals Provides Fourth Quarter 2010 Investor Update
02/28/2011 BW Ironwood Pharmaceuticals to Host Fourth Quarter 2010 Investor Update Call
11/05/2010 BW Ironwood Pharmaceuticals Announces Upcoming Presentation at Credit Suisse 2010 Healthcare Conference
11/04/2010 BW Ironwood Pharmaceuticals Provides Third Quarter 2010 Investor Update
11/01/2010 BW Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results
11/01/2010 BW Almirall and Ironwood Announce Positive Results from the Second Phase 3 Trial of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
09/09/2010 BW Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference
08/02/2010 BW Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call
07/28/2010 BW Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010
05/11/2010 BW Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update
05/07/2010 BW Ironwood Pharmaceuticals Announces First Quarter 2010 Investor Update Call and Upcoming Presentation at Bank of America Merrill Lynch 2010 Health Care Conference
03/30/2010 BW Ironwood Pharmaceuticals Files Annual Report on Form 10-K

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy